Some alterations were found in both populations, as high tumor mutation burden (TMB) >10 muts/Mb (17.6% and 17.0%, respectively) and alterations affecting PI3K/mTOR (37% and 33%, respectively), while others were more frequent in the Chinese population (i.e., mutations in ERBB family, 31% vs. 19%, p = 0.04) [20]. Here, EGFR is linked to neoplasm.